Table 3 Reasons for rituximab discontinuation by indication
Rituximab discontinuation | RA n = 68 | CTD n = 35 | Vasculitis n = 19 | Other n = 16 | All n = 138 |
|---|---|---|---|---|---|
Remission, n (%) | 7 (10.3) | 9 (25.7) | 13 (68.4) | 2 (12.5) | 31 (22.5) |
Inefficacy, n (%) | 36 (52.9) | 19 (54.3) | 4 (21.1) | 12 (75.0) | 71 (51.5) |
Adverse event, n (%) | 25 (36.8) | 7 (20.0) | 2 (10.5) | 2 (12.5) | 36 (26.1) |